Virologic resistance analysis from a phase 2 study of MK-5172 combined with pegylated interferon/ribavirin in treatment-naive patients with hepatitis C virus genotype 1 infection.
Howe AY et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 2014